SYMBRAVO FDA approval date

The FDA approved SYMBRAVO on 30 Jan 2025.

FDA approval date
30 Jan 2025

Drug identity has not yet been verified against registry records

Also recorded as MELOXICAM; RIZATRIPTAN BENZOATE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2025-01-30DaySYMBRAVOFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA215431", "applicant_as_listed_by_fda": "AXSOME", "brand_names": ["SYMBRAVO"], "active_ingredients": ["MELOXICAM", "RIZATRIPTAN BENZOATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20250130", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026